Treatment Guidelines: Medication-Induced Movement Disorders

Medication-induced movement disorders are a variety of iatrogenic and clinically distinct movement disorders that can range from tremors to life-threatening syndromes. These are categorized based on the time of onset after drug ingestion (acute, subacute, or tardive).

American Academy of Neurology

• Essential Tremor Quality Measurement Set  (2017)
• Treatment of Essential Tremor (2011, reaffirmed 2022)
• Treatment of Restless Leg Syndrome in Adults (2016, reaffirmed in 2022)
• Tardive Syndromes (2013, reaffirmed in 2019, retired 2022)

American Psychiatric Association

• Practice Guideline for the Treatment of Patients with Schizophrenia  (2020)

British Association of Psychopharmacology

• Guidelines for the Pharmacological Treatment of Schizophrenia (see section “Extrapyramidal side effects,” pages 27-31) (2019)

World Federation of Societies of Biological Psychiatry:

• Guidelines for Biological Treatment of Schizophrenia (2013)

Reviewer 1: Trisha McHugh, PharmD
Reviewer 2: Leah Rickert, PharmD, BCPP
Reviewer 3: Austin Smith, PharmD, BCPP
2023-2024 AAPP Resident and New Practitioner Committee